River Wealth Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,246
Closed -$217K 204
2024
Q1
$217K Sell
2,246
-764
-25% -$78.3K 0.03% 198
2023
Q4
$304K Buy
+3,010
New +$291K 0.05% 171
2023
Q1
Sell
-2,771
Closed -$251K 211
2022
Q4
$251K Sell
2,771
-422
-13% -$35.5K 0.05% 189
2022
Q3
$243K Buy
3,193
+740
+30% +$61.3K 0.05% 182
2022
Q2
$207K Buy
2,453
+122
+5% +$10.7K 0.04% 207
2022
Q1
$205K Sell
2,331
-87
-4% -$7.53K 0.03% 219
2021
Q4
$212K Sell
2,418
-268
-10% -$22.3K 0.03% 217
2021
Q3
$220K Sell
2,686
-20
-0.7% -$1.8K 0.04% 210
2021
Q2
$247K Buy
2,706
+181
+7% +$16.1K 0.04% 195
2021
Q1
$216K Buy
2,525
+100
+4% +$8.97K 0.04% 203
2020
Q4
$229K Sell
2,425
-72
-3% -$6.29K 0.05% 193
2020
Q3
$217K Buy
+2,497
New +$216K 0.06% 188
2019
Q1
Sell
-1,700
Closed -$131K 374
2018
Q4
$131K Hold
1,700
0.06% 174
2018
Q3
$131K Sell
1,700
-238
-12% -$17.6K 0.05% 187
2018
Q2
$131K Buy
+1,938
New +$134K 0.05% 185

Other funds holding NVS

River Wealth Advisors's NVS Position: Q2 2024 in Review

River Wealth Advisors sold out of Novartis (NVS) in Q2 2024, closing a stake of 2,246 shares — an estimated $217K sold.

River Wealth Advisors first reported a position in NVS in Q2 2018 and held it in 15 quarters. The position peaked at $304K in Q4 2023. 1,306 funds tracked by Wall St. Rank hold NVS as of Q2 2024.

  • River Wealth Advisors reported no remaining Novartis position as of Q2 2024 after selling out during the quarter.
  • River Wealth Advisors sold 2,246 Novartis shares in Q2 2024, an estimated $217K.
  • River Wealth Advisors first reported a position in Novartis in Q2 2018 and held it in 15 quarters.
  • River Wealth Advisors's Novartis position peaked at $304K in Q4 2023.
  • 1,306 funds tracked by Wall St. Rank held Novartis as of Q2 2024.

Based on River Wealth Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.